42,60EUR | 0,00 EUR | 0,00 %
DAX+1,27 % EUR/USD+0,01 % Gold+0,01 % Öl (Brent)-0,60 %

Diskussion zu Cann Trust Holdings

Beitrag schreiben

Begriffe und/oder Benutzer


CannTrust beliefert Australien und Deutschland
VAUGHAN, ON, Nov. 8, 2017 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company" I CSE: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation (" ACMPR ") program, is pleased to announce that it has received Health Canada approval to export medical marijuana internationally to Countries where medical marijuana is legalized and that the Company has now begun shipping to Australia.

"We are very proud and excited to begin the international shipping of our pharmaceutically standardized medical marijuana products. Australia is the first of many markets that we are expecting to supply. Other countries that we anticipate shipping to shortly are Germany, Denmark and Brazil", said Brad Rogers, President of CannTrust Inc.

Rogers continued "Germany has implemented one of the most progressive medical marijuana Plans whereby marijuana will be distributed via Pharmacies with Insurers required to cover the costs just as they do for Pharmaceutical drugs. CannTrust is an experienced and advanced Licensed Producer of Pharmaceutical grade cannabis in Canada and our recently completed Phase 1 of our 430,000 square feet Niagara Facility, is perfectly timed in order for us to supply the orders we have received. The pending legislation to legalize the adult consumer recreational use of cannabis provides a further major opportunity for the Company. With the completion of all phases of our Niagara expansion we plan to have in excess of 1,000,000 square feet of production capacity. This will give us the ability to acquire a substantial share of the increased demand arising from these new markets."

Company CEO Eric Paul, a veteran Pharmacist, said "Our plan was always to be a Pharmaceutical Company producing quality medical cannabis in a variety of unique dosage forms that will provide the best treatment options for patients. Our shipments to Australia are just the beginning of what we believe will be a World market opportunity for us along with our exclusive global pharma manufacturing partner, Apotex Inc., for our Canadian made, pharmaceutically standardized, cannabis products."
Es gibt es eine kleine Handvoll kanadischer Cannabiszüchter, die wesentlich billiger sind als ihre Kollegen. CannTrust Holdings (WKN:A2DWH4), das im dritten Quartal mehr als die Hälfte seines Umsatzes mit Cannabis-Ölen erzielte, ist ein solches Unternehmen. Das KGV von CannTrust, das derzeit nur auf das 26-fache des erwarteten Gewinns geschätzt wird

TD Bank opens up to cannabis sector:

As with any emerging sector, investments in legal marijuana businesses are risky. Most of the companies are startups and have booked little to no revenue. Yet, many investors are upbeat about their prospects, pouring millions into the sector despite the many unknowns – all in the hopes of cashing in on the green rush as countries around the world legalize and regulate cannabis.

Here’s the full list of pot stocks that TD has approved:

Canopy Growth Corp. (WEED)

Emblem Corp. (EMC) Emerald Health Therapeutics (EMH)

Cronos Group Inc. (CRON) Naturally Splendid Ent Ltd. (NSP)

Weedmd Inc. (WMD) Tetra Bio-Pharma Inc. (TBP) Supreme Cannabis Co. Inc. (FIRE)

Medreleaf Corp. (LEAF) Hydropothecary Corp. (HEXO)

Abcann Global Corp. (ABCN) Newstrike Resources Ltd. (HIP)

ICC Labs Inc. (ICC) Harvest One Cannabis Inc. (HVT)

Delta 9 Cannabis Inc. (NINE) National Access Cannabis Corp. (META)

CBD Med Research Corp. (CBM/H)

Neptune Technologies & Bioress (NEPT)

Canntrust Holdings Inc. (TRST)

CannTrust Continues Global Expansion as Danish Partner, STENOCARE, Receives License to Distribute CannTrust Products.


Kleines Beispiel dafür, was neben Zigaretten und Getränken noch alles möglich ist(und auf uns zukommt).

Beitrag zu dieser Diskussion schreiben